 Neuronal ceroid-lipofuscinosis preferential metabolic alterations thalamus posterior association cortex PET Regional brain glucose utilisation positron emission tomography PET fluorodeoxyglucose FDG siblings neuronal ceroid-lipofuscinosis consistent pattern decrease glucose utilisation grey structures marked level thalamus posterior association cortex severity metabolic anomalies degree clinical impairment disease duration severe patient affected intermediate others minimal subject shortest period development disease observations PET useful definition anatomical targets metabolic diseases investigation pathophysiology